STAT3 in Prostate Cancer: Whom Should We Treat and When?

被引：7

作者：

Culig, Zoran ^{[1
]}

机构：

[1] Med Univ Innsbruck, Dept Urol, Expt Urol, Anichstr 35, A-6020 Innsbruck, Austria

来源：

EUROPEAN UROLOGY | 2017年 / 71卷 / 03期

关键词：

INTERLEUKIN-6; CELLS; ANTIBODY; GROWTH; MICE;

D O I：

10.1016/j.eururo.2016.06.034

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：317 / 318

页数：2

共 10 条

[1] EC-70124, a Novel Glycosylated Indolocarbazole Multikinase Inhibitor, Reverts Tumorigenic and Stem Cell Properties in Prostate Cancer by Inhibiting STAT3 and NF-κB [J].

Civenni, Gianluca ;

Longoni, Nicole ;

Costales, Paula ;

Dallavalle, Cecilia ;

Inclan, Cristina Garcia ;

Albino, Domenico ;

Nunez, Luz Elena ;

Moris, Francisco ;

Carbone, Giuseppina M. ;

Catapano, Carlo V. .

MOLECULAR CANCER THERAPEUTICS, 2016, 15 (05) :806-818

[2] Expression of STAT3 in Prostate Cancer Metastases [J].

Don-Doncow, Nicholas ;

Marginean, Felicia ;

Coleman, Ilsa ;

Nelson, Peter S. ;

Ehrnstrom, Roy ;

Krzyzanowska, Agnieszka ;

Morrissey, Colm ;

Hellsten, Rebecka ;

Bjartell, Anders .

EUROPEAN UROLOGY, 2017, 71 (03) :313-316

[3] Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer [J].

Dorff, Tanya B. ;

Goldman, Bryan ;

Pinski, Jacek K. ;

Mack, Philip C. ;

Lara, Primo N., Jr. ;

Van Veldhuizen, Peter J., Jr. ;

Quinn, David I. ;

Vogelzang, Nicholas J. ;

Thompson, Ian M., Jr. ;

Hussain, Maha H. A. .

CLINICAL CANCER RESEARCH, 2010, 16 (11) :3028-3034

[4] JAK-STAT Blockade Inhibits Tumor Initiation and Clonogenic Recovery of Prostate Cancer Stem-like Cells [J].

Kroon, Paula ;

Berry, Paul A. ;

Stower, Michael J. ;

Rodrigues, Greta ;

Mann, Vincent M. ;

Simms, Matthew ;

Bhasin, Deepak ;

Chettiar, Somsundaram ;

Li, Chenglong ;

Li, Pui-Kai ;

Maitland, Norman J. ;

Collins, Anne T. .

CANCER RESEARCH, 2013, 73 (16) :5288-5298

[5] IL-6 Overexpression in ERG-Positive Prostate Cancer Is Mediated by Prostaglandin Receptor EP2 [J].

Merz, Constanze ;

von Maessenhausen, Anne ;

Queisser, Angela ;

Vogel, Wenzel ;

Andren, Ove ;

Kirfel, Jutta ;

Duensing, Stefan ;

Perner, Sven ;

Nowak, Michael .

AMERICAN JOURNAL OF PATHOLOGY, 2016, 186 (04) :974-984

[6] TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells [J].

Moreira, Dayson ;

Zhang, Qifang ;

Hossain, Dewan Md S. ;

Nechaev, Sergey ;

Li, Haiqing ;

Kowolik, Claudia M. ;

D'Apuzzo, Massimo ;

Forman, Stephen ;

Jones, Jeremy ;

Pal, Sumanta K. ;

Kortylewski, Marcin .

ONCOTARGET, 2015, 6 (19) :17302-17313

[7] STAT3 regulated ARF expression suppresses prostate cancer metastasis [J].

Pencik, Jan ;

Schlederer, Michaela ;

Gruber, Wolfgang ;

Unger, Christine ;

Walker, Steven M. ;

Chalaris, Athena ;

Marie, Isabelle J. ;

Hassler, Melanie R. ;

Javaheri, Tahereh ;

Aksoy, Osman ;

Blayney, Jaine K. ;

Prutsch, Nicole ;

Skucha, Anna ;

Herac, Merima ;

Kraemer, Oliver H. ;

Mazal, Peter ;

Grebien, Florian ;

Egger, Gerda ;

Poli, Valeria ;

Mikulits, Wolfgang ;

Eferl, Robert ;

Esterbauer, Harald ;

Kennedy, Richard ;

Fend, Falko ;

Scharpf, Marcus ;

Braun, Martin ;

Perner, Sven ;

Levy, David E. ;

Malcolm, Tim ;

Turner, Suzanne D. ;

Haitel, Andrea ;

Susani, Martin ;

Moazzami, Ali ;

Rose-John, Stefan ;

Aberger, Fritz ;

Merkel, Olaf ;

Moriggl, Richard ;

Culig, Zoran ;

Dolznig, Helmut ;

Kenner, Lukas .

NATURE COMMUNICATIONS, 2015, 6

[8] Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328 [J].

Steiner, Hannes ;

Cavarretta, Ilaria T. ;

Moser, Patrizia L. ;

Berger, Andreas P. ;

Bektic, Jasmin ;

Dietrich, Hermann ;

Zaki, Mohamed H. ;

Nakada, Marian ;

Hobisch, Alfred ;

Nemeth, Jeffrey A. ;

Culig, Zoran .

PROSTATE, 2006, 66 (16) :1744-1752

[9] Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice [J].

Wallner, L ;

Dai, JL ;

Escara-Wilke, J ;

Zhang, J ;

Yao, Z ;

Lu, Y ;

Trikha, M ;

Nemeth, JA ;

Zaki, MH ;

Keller, ET .

CANCER RESEARCH, 2006, 66 (06) :3087-3095

[10] Interleukin-6 inhibits the growth of prostate cancer xenografts in mice by the process of neuroendocrine differentiation [J].

Wang, QC ;

Horiatis, D ;

Pinski, J .

INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (04) :508-513

← 1 →